Senate OKs big NIH bump

The US Senate, which is furiously debating the details of the economic stimulus package making its way through Congress, passed an amendment yesterday (Feb. 3) to add $6.5 billion in National Institutes of Health funding on top of the $3.5 billion already allotted to the agency in the bill. Science advocacy groups praised passage of the amendment, which was sponsored by Senators Arlen Specter (R-PA), Tom Harkin (D-IA) and Dick Durbin (D-IL). linkurl:Richard Marchase,;http://main.uab.edu/show.a

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The US Senate, which is furiously debating the details of the economic stimulus package making its way through Congress, passed an amendment yesterday (Feb. 3) to add $6.5 billion in National Institutes of Health funding on top of the $3.5 billion already allotted to the agency in the bill. Science advocacy groups praised passage of the amendment, which was sponsored by Senators Arlen Specter (R-PA), Tom Harkin (D-IA) and Dick Durbin (D-IL). linkurl:Richard Marchase,;http://main.uab.edu/show.asp?durki=8039 president of the Federation of American Societies for Experimental Biology (FASEB), said that the sponsors of the amendment were "champions of biomedical research," in a statement. "Millions of Americans who suffer from devastating illnesses like cancer and Alzheimer's disease, as well as the hundreds of thousands whose jobs depend on NIH funding, owe a great deal to these leaders," he added. "It is our hope that the economic recovery package is one step forward towards a long-term, sustainable investment in medical research." linkurl:John Morrison,;http://www.mountsinai.org/Find%20A%20Faculty/profile.do?id=0000072500001497270992 the chair of Society for Neuroscience's (SfN) government and public affairs committee, added his encouragement for the NIH budget bump. "SfN applauds the efforts of Sen. Arlen Specter (R-PA) and others to provide $10 billion for the National Institutes of Health in the economic recovery package, helping to save and create jobs now while investing in our nation's long term health and economic strength," he said in a statement emailed to __The Scientist__. "SfN sees the economic recovery package as a first step of what must be a long-term national commitment to prioritize and stabilize research funding." The House (with no support from Republicans) passed a version of the stimulus bill, which provided $3.5 billion in NIH funding, last week. Democrats and Republicans in the Congress will continue thrashing out the finer points of the bill, and the legislature is expected to have a version ready for President Barack Obama to sign by mid-February. Exactly how an NIH funding increase will be spent remains to be determined.
**__Related stories:__***linkurl:Bailing out life science;http://www.the-scientist.com/blog/display/55338/
[15th January 2009]*linkurl:$500 million NIH funds boost?;http://www.the-scientist.com/blog/display/55016/
[17th September 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform